{
    "title": "Estimating Treatment Effects using Multiple Surrogates: The Role of the Surrogate Score and the Surrogate Index",
    "abstract": "arXiv:1603.09326v4 Announce Type: replace-cross  Abstract: Estimating the long-term effects of treatments is of interest in many fields. A common challenge in estimating such treatment effects is that long-term outcomes are unobserved in the time frame needed to make policy decisions. One approach to overcome this missing data problem is to analyze treatments effects on an intermediate outcome, often called a statistical surrogate, if it satisfies the condition that treatment and outcome are independent conditional on the statistical surrogate. The validity of the surrogacy condition is often controversial. Here we exploit that fact that in modern datasets, researchers often observe a large number, possibly hundreds or thousands, of intermediate outcomes, thought to lie on or close to the causal chain between the treatment and the long-term outcome of interest. Even if none of the individual proxies satisfies the statistical surrogacy criterion by itself, using multiple proxies can be ",
    "link": "https://arxiv.org/abs/1603.09326",
    "context": "Title: Estimating Treatment Effects using Multiple Surrogates: The Role of the Surrogate Score and the Surrogate Index\nAbstract: arXiv:1603.09326v4 Announce Type: replace-cross  Abstract: Estimating the long-term effects of treatments is of interest in many fields. A common challenge in estimating such treatment effects is that long-term outcomes are unobserved in the time frame needed to make policy decisions. One approach to overcome this missing data problem is to analyze treatments effects on an intermediate outcome, often called a statistical surrogate, if it satisfies the condition that treatment and outcome are independent conditional on the statistical surrogate. The validity of the surrogacy condition is often controversial. Here we exploit that fact that in modern datasets, researchers often observe a large number, possibly hundreds or thousands, of intermediate outcomes, thought to lie on or close to the causal chain between the treatment and the long-term outcome of interest. Even if none of the individual proxies satisfies the statistical surrogacy criterion by itself, using multiple proxies can be ",
    "path": "papers/16/03/1603.09326.json",
    "total_tokens": 835,
    "translated_title": "利用多个替代指标估计治疗效果：替代分数和替代指数的作用",
    "translated_abstract": "估计治疗效果长期作用是许多领域感兴趣的问题。 估计此类治疗效果的一个常见挑战在于长期结果在需要做出政策决策的时间范围内是未观察到的。 克服这种缺失数据问题的一种方法是分析治疗效果对中间结果的影响，通常称为统计替代指标，如果满足条件：在统计替代指标的条件下，治疗和结果是独立的。  替代条件的有效性经常是有争议的。 在现代数据集中，研究人员通常观察到大量中间结果，可能是数百个或数千个，被认为位于治疗和长期感兴趣的结果之间的因果链上或附近。 即使没有个别代理满足统计替代条件，使用多个代理也可以。",
    "tldr": "利用现代数据集中大量中间结果的事实，即使没有单个替代指标满足统计替代条件，使用多个替代指标也可能是有效的。",
    "en_tdlr": "Leveraging the presence of a large number of intermediate outcomes in modern datasets, using multiple surrogates can be effective even if none of them individually meets the statistical surrogate criterion."
}